TrialThe oncologist2021

Preemptive Versus Reactive Topical Clobetasol for Regorafenib-Induced Hand-Foot Reactions: A Preplanned Analysis of the ReDOS Trial.

Aminah Jatoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.